Evidence map›Paper›PMID 42404991›Full record

ArticleCanadian liver journal2026

Frequency of

David Mp Di Fonzo, Yu-Chen Luo, Daljeet Chahal, Isabella Tai

Abstract read
In one paragraph

Article in Canadian liver journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

David Mp Di FonzoDepartment of Gastroenterology and Hepatology, University of British Columbia, Vancouver, British Columbia, Canada.
Yu-Chen LuoDepartment of Gastroenterology and Hepatology, University of British Columbia, Vancouver, British Columbia, Canada.
Daljeet ChahalDepartment of Gastroenterology and Hepatology, University of British Columbia, Vancouver, British Columbia, Canada.
Isabella TaiDepartment of Gastroenterology and Hepatology, University of British Columbia, Vancouver, British Columbia, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Post-transplant immunosuppression increases malignancy risk. Gastric cancer is one of the most common post-transplant malignancies among high-risk groups including Asian patients. Methods: We conducted a retrospective chart review of 127 patients who underwent upper endoscopy prior to liver transplant. Data were collected for age, ethnicity, indications for endoscopy, endoscopic findings, endoscopic treatment, gastric biopsy results, and antibiotic/proton pump inhibitor use. Non-endoscopic Results: Among 127 patients, 15 were of Asian and 9 were of Indigenous heritage. The most common indication for endoscopy was variceal surveillance (83 patients), then gastrointestinal bleeding (33 patients). Thirty-nine patients had biopsies taken for Conclusions:

Indexed as

ethnic disparitiesgastric cancerHelicobacter pyloriH. pylori screeningliver transplant

Identifiers

PMID42404991
PMCPMC13331623

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.